Showing results (61-70 of 94) with videos related to
Sort By:
Pageof 10
Journal of Parkinson'S Disease|December 13, 2021
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialM Judith Peterschmitt, Hidemoto Saiki, Taku Hatano, et al.Nature Neuroscience|November 29, 2018
Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric diseaseXianjun Dong, Zhixiang Liao, David Gritsch, et al.Nature Neuroscience|September 19, 2018
Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric diseaseXianjun Dong, Zhixiang Liao, David Gritsch, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 3, 2025
Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's DiseaseYu Liao, Hao Wu, Junhao Wang, et al.Neurology|January 29, 2026
Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related DementiasPia Kivisäkk, Hadia Fatima, Chao-Yi Wu, et al.Annals of Neurology|June 29, 2016
Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patientsShuko Takeda, Caitlin Commins, Sarah L DeVos, et al.Neurology|June 17, 2020
β-Glucocerebrosidase activity in GBA-linked Parkinson disease: The type of mutation mattersYoung Eun Huh, Ming Sum Ruby Chiang, Joseph J Locascio, et al.Biorxiv : the Preprint Server for Biology|August 26, 2024
Experimental and Computational Methods for Allelic Imbalance Analysis from Single-Nucleus RNA-seq DataSean K Simmons, Xian Adiconis, Nathan Haywood, et al.Science (New York, N.Y.)|September 2, 2017
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's diseaseShuchi Mittal, Kjetil Bjørnevik, Doo Soon Im, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 8, 2015
The NINDS Parkinson's disease biomarkers programLiana S Rosenthal, Daniel Drake, Roy N Alcalay, et al.Pageof 10